適時開示情報
- 2025/07/08
- JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
- 2025/07/02
- JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial
TD-net(適時開示情報閲覧サービス)にて開示された情報を掲載しております。